
(AGENPARL) – SILVER SPRING gio 13 aprile 2023 VAXELIS is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae (H. influenzae) type b. VAXELIS is approved for use as a 3 dose series in children 6 weeks through 4 years of age (prior t
Fonte/Source: http://www.fda.gov/vaccines-blood-biologics/vaxelis